APA (7th ed.) Citation

T, U., SB, P., T, I., M, Z., JN, A., K, C., & TJ, L. (2021). Genetically edited hepatic cells expressing the NTCP-S267F variant are resistant to hepatitis B virus infection. Molecular therapy. Methods & clinical development, 23, 597. https://doi.org/10.1016/j.omtm.2021.11.002

Chicago Style (17th ed.) Citation

T, Uchida, Park SB, Inuzuka T, Zhang M, Allen JN, Chayama K, and Liang TJ. "Genetically Edited Hepatic Cells Expressing the NTCP-S267F Variant Are Resistant to Hepatitis B Virus Infection." Molecular Therapy. Methods & Clinical Development 23 (2021): 597. https://doi.org/10.1016/j.omtm.2021.11.002.

MLA (9th ed.) Citation

T, Uchida, et al. "Genetically Edited Hepatic Cells Expressing the NTCP-S267F Variant Are Resistant to Hepatitis B Virus Infection." Molecular Therapy. Methods & Clinical Development, vol. 23, 2021, p. 597, https://doi.org/10.1016/j.omtm.2021.11.002.